rs1370274

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000137.4(FAH):​c.193-23T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.604 in 1,613,044 control chromosomes in the GnomAD database, including 296,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27377 hom., cov: 32)
Exomes 𝑓: 0.60 ( 269405 hom. )

Consequence

FAH
NM_000137.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.137

Publications

8 publications found
Variant links:
Genes affected
FAH (HGNC:3579): (fumarylacetoacetate hydrolase) Predicted to enable fumarylacetoacetase activity. Predicted to be involved in L-phenylalanine catabolic process; homogentisate catabolic process; and tyrosine catabolic process. Predicted to act upstream of or within arginine catabolic process. Located in extracellular exosome. Implicated in tyrosinemia type I. [provided by Alliance of Genome Resources, Apr 2022]
FAH Gene-Disease associations (from GenCC):
  • tyrosinemia type I
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-80159733-T-C is Benign according to our data. Variant chr15-80159733-T-C is described in ClinVar as Benign. ClinVar VariationId is 255279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.761 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000137.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAH
NM_000137.4
MANE Select
c.193-23T>C
intron
N/ANP_000128.1A0A384P5L6
FAH
NM_001374377.1
c.193-23T>C
intron
N/ANP_001361306.1A0A384P5L6
FAH
NM_001374380.1
c.193-23T>C
intron
N/ANP_001361309.1A0A384P5L6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAH
ENST00000561421.6
TSL:1 MANE Select
c.193-23T>C
intron
N/AENSP00000453347.2P16930-1
FAH
ENST00000539156.5
TSL:1
n.2221-23T>C
intron
N/A
FAH
ENST00000874657.1
c.295-23T>C
intron
N/AENSP00000544716.1

Frequencies

GnomAD3 genomes
AF:
0.598
AC:
90895
AN:
151952
Hom.:
27368
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.611
Gnomad AMI
AF:
0.654
Gnomad AMR
AF:
0.533
Gnomad ASJ
AF:
0.610
Gnomad EAS
AF:
0.781
Gnomad SAS
AF:
0.680
Gnomad FIN
AF:
0.504
Gnomad MID
AF:
0.677
Gnomad NFE
AF:
0.599
Gnomad OTH
AF:
0.600
GnomAD2 exomes
AF:
0.602
AC:
151352
AN:
251466
AF XY:
0.608
show subpopulations
Gnomad AFR exome
AF:
0.612
Gnomad AMR exome
AF:
0.488
Gnomad ASJ exome
AF:
0.617
Gnomad EAS exome
AF:
0.785
Gnomad FIN exome
AF:
0.513
Gnomad NFE exome
AF:
0.597
Gnomad OTH exome
AF:
0.580
GnomAD4 exome
AF:
0.605
AC:
883318
AN:
1460974
Hom.:
269405
Cov.:
45
AF XY:
0.607
AC XY:
441432
AN XY:
726852
show subpopulations
African (AFR)
AF:
0.608
AC:
20329
AN:
33462
American (AMR)
AF:
0.492
AC:
22008
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.613
AC:
16024
AN:
26128
East Asian (EAS)
AF:
0.799
AC:
31698
AN:
39694
South Asian (SAS)
AF:
0.698
AC:
60228
AN:
86238
European-Finnish (FIN)
AF:
0.517
AC:
27614
AN:
53406
Middle Eastern (MID)
AF:
0.658
AC:
3794
AN:
5764
European-Non Finnish (NFE)
AF:
0.598
AC:
664704
AN:
1111200
Other (OTH)
AF:
0.612
AC:
36919
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
17630
35260
52889
70519
88149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18196
36392
54588
72784
90980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.598
AC:
90953
AN:
152070
Hom.:
27377
Cov.:
32
AF XY:
0.594
AC XY:
44198
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.611
AC:
25322
AN:
41474
American (AMR)
AF:
0.532
AC:
8134
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.610
AC:
2117
AN:
3472
East Asian (EAS)
AF:
0.782
AC:
4047
AN:
5178
South Asian (SAS)
AF:
0.679
AC:
3274
AN:
4820
European-Finnish (FIN)
AF:
0.504
AC:
5319
AN:
10562
Middle Eastern (MID)
AF:
0.684
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
0.599
AC:
40682
AN:
67966
Other (OTH)
AF:
0.598
AC:
1261
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1905
3810
5714
7619
9524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.604
Hom.:
15790
Bravo
AF:
0.596
Asia WGS
AF:
0.670
AC:
2331
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
2
Tyrosinemia type I (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
7.0
DANN
Benign
0.81
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1370274; hg19: chr15-80452075; COSMIC: COSV55720602; COSMIC: COSV55720602; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.